ATA214588A - Pharmazeutische dosierungsform zur kontrollierten abgabe von diltiazem - Google Patents

Pharmazeutische dosierungsform zur kontrollierten abgabe von diltiazem

Info

Publication number
ATA214588A
ATA214588A AT2145/88A AT214588A ATA214588A AT A214588 A ATA214588 A AT A214588A AT 2145/88 A AT2145/88 A AT 2145/88A AT 214588 A AT214588 A AT 214588A AT A214588 A ATA214588 A AT A214588A
Authority
AT
Austria
Prior art keywords
diltiazem
dosage form
pharmaceutical dosage
controlled delivery
delivery
Prior art date
Application number
AT2145/88A
Other languages
English (en)
Other versions
AT394311B (de
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of ATA214588A publication Critical patent/ATA214588A/de
Application granted granted Critical
Publication of AT394311B publication Critical patent/AT394311B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT0214588A 1988-06-02 1988-09-01 Pharmazeutische dosierungsform zur kontrollierten abgabe von diltiazem AT394311B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/201,519 US4859470A (en) 1988-06-02 1988-06-02 Dosage form for delivering diltiazem

Publications (2)

Publication Number Publication Date
ATA214588A true ATA214588A (de) 1991-09-15
AT394311B AT394311B (de) 1992-03-10

Family

ID=22746162

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0214588A AT394311B (de) 1988-06-02 1988-09-01 Pharmazeutische dosierungsform zur kontrollierten abgabe von diltiazem

Country Status (25)

Country Link
US (1) US4859470A (de)
JP (1) JP2590226B2 (de)
KR (1) KR960006062B1 (de)
AR (1) AR241635A1 (de)
AT (1) AT394311B (de)
AU (1) AU612398B2 (de)
BE (1) BE1001935A3 (de)
CA (1) CA1311687C (de)
CH (1) CH675208A5 (de)
DE (1) DE3829941C2 (de)
DK (1) DK175396B1 (de)
ES (1) ES2008813A6 (de)
FI (1) FI92553C (de)
FR (1) FR2632306B1 (de)
GB (1) GB2219205B (de)
GR (1) GR1000197B (de)
IE (1) IE61861B1 (de)
IT (1) IT1223799B (de)
LU (1) LU87327A1 (de)
MX (1) MX174157B (de)
NL (1) NL194747C (de)
NO (1) NO174766C (de)
PT (1) PT88405B (de)
SE (1) SE503508C2 (de)
ZA (1) ZA886436B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5108756A (en) * 1989-01-12 1992-04-28 Pfizer Inc. Dispensing devices powered by lyotropic liquid crystals
US5030452A (en) * 1989-01-12 1991-07-09 Pfizer Inc. Dispensing devices powered by lyotropic liquid crystals
IL92966A (en) * 1989-01-12 1995-07-31 Pfizer Dispensing devices powered by hydrogel
US5112614A (en) * 1989-09-14 1992-05-12 Alza Corporation Implantable delivery dispenser
US5208037A (en) * 1991-04-22 1993-05-04 Alza Corporation Dosage forms comprising polymers comprising different molecular weights
US6283951B1 (en) * 1996-10-11 2001-09-04 Transvascular, Inc. Systems and methods for delivering drugs to selected locations within the body
US6524620B2 (en) 1998-07-20 2003-02-25 Andrx Pharmaceuticals, Inc. Diltiazem controlled release formulation and method of manufacture
US6562375B1 (en) 1999-08-04 2003-05-13 Yamanouchi Pharmaceuticals, Co., Ltd. Stable pharmaceutical composition for oral use
PT1205190E (pt) * 1999-08-04 2006-09-29 Astellas Pharma Inc Composicoes medicinais estaveis para uso oral utilizando oxidos de ferro
US20060153914A1 (en) * 1999-12-10 2006-07-13 Biovail Laboratories International S.R.L. Chronotherapeutic diltiazem formulations and the administration thereof
US7108866B1 (en) 1999-12-10 2006-09-19 Biovall Laboratories International Srl Chronotherapeutic diltiazem formulations and the administration thereof
US6352721B1 (en) * 2000-01-14 2002-03-05 Osmotica Corp. Combined diffusion/osmotic pumping drug delivery system
US6753011B2 (en) 2000-01-14 2004-06-22 Osmotica Corp Combined diffusion/osmotic pumping drug delivery system
MY142204A (en) * 2002-07-25 2010-10-29 Pharmacia Corp Pramipexole once-daily dosage form
BRPI0513848A (pt) 2004-08-13 2008-05-20 Boehringer Ingelheim Int formulação de pélete de liberação prolongada contendo pramipexol ou um sal farmaceuticamente aceitável deste, método para fabricação da mesma e uso desta
PH12012501282A1 (en) 2004-08-13 2019-03-22 Boehringer Ingelheim Int Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) * 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
GB1478759A (en) * 1974-11-18 1977-07-06 Alza Corp Process for forming outlet passageways in pills using a laser
US4063064A (en) * 1976-02-23 1977-12-13 Coherent Radiation Apparatus for tracking moving workpiece by a laser beam
US4111202A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system for the controlled and delivery of agent over time
US4160452A (en) * 1977-04-07 1979-07-10 Alza Corporation Osmotic system having laminated wall comprising semipermeable lamina and microporous lamina
US4285987A (en) * 1978-10-23 1981-08-25 Alza Corporation Process for manufacturing device with dispersion zone
US4200098A (en) * 1978-10-23 1980-04-29 Alza Corporation Osmotic system with distribution zone for dispensing beneficial agent
US4235236A (en) * 1979-02-12 1980-11-25 Alza Corporation Device for dispensing drug by combined diffusional and osmotic operations
IT1153487B (it) * 1982-04-15 1987-01-14 Prophin Lab Spa Prodotti farmaceutici in forma-ritardo e procedimento per ottenerli
NZ206600A (en) * 1983-05-11 1987-01-23 Alza Corp Osmotic drug delivery device
US4783337A (en) * 1983-05-11 1988-11-08 Alza Corporation Osmotic system comprising plurality of members for dispensing drug
IE56999B1 (en) * 1983-12-22 1992-03-11 Elan Corp Plc Pharmaceutical formulation
IT1206166B (it) * 1984-07-26 1989-04-14 Sigma Tau Ind Farmaceuti Dispositivo per rilasciare una sostanza in un fluido di dissoluzione con cinetica di ordine zero e procedimento per la sua preparazione
US4624847A (en) * 1985-04-22 1986-11-25 Alza Corporation Drug delivery device for programmed delivery of beneficial drug
DE3681348D1 (de) * 1985-06-11 1991-10-17 Teijin Ltd Oral-arzneizubereitung mit retardwirkung.
US4753802A (en) * 1986-03-19 1988-06-28 Alza Corporation Verapamil dosage form
ES2032205T3 (es) * 1986-11-14 1993-01-16 Ciba-Geigy Ag Procedimiento para la obtencion de un sistema osmotico oral para la administracion de metoprolol.

Also Published As

Publication number Publication date
AU2152788A (en) 1989-12-07
SE8803085D0 (sv) 1988-09-02
SE503508C2 (sv) 1996-06-24
DK485688D0 (da) 1988-09-01
AR241635A1 (es) 1992-10-30
LU87327A1 (fr) 1989-03-08
NO883838D0 (no) 1988-08-29
FI884057L (fi) 1989-12-03
KR960006062B1 (ko) 1996-05-08
US4859470A (en) 1989-08-22
GB2219205A (en) 1989-12-06
DE3829941A1 (de) 1989-12-14
BE1001935A3 (fr) 1990-04-17
KR900000076A (ko) 1990-01-30
PT88405A (pt) 1990-06-29
GB8820461D0 (en) 1988-09-28
PT88405B (pt) 1995-07-18
NL194747B (nl) 2002-10-01
NO174766B (no) 1994-03-28
JPH01313432A (ja) 1989-12-18
GR880100574A (en) 1990-05-11
IE882642L (en) 1989-12-02
NL8802181A (nl) 1990-01-02
IE61861B1 (en) 1994-11-30
FR2632306A1 (fr) 1989-12-08
FR2632306B1 (fr) 1990-11-16
DE3829941C2 (de) 1997-07-03
JP2590226B2 (ja) 1997-03-12
AT394311B (de) 1992-03-10
ZA886436B (en) 1989-05-30
DK175396B1 (da) 2004-09-27
SE8803085L (sv) 1989-12-03
CA1311687C (en) 1992-12-22
GB2219205B (en) 1992-07-15
NL194747C (nl) 2003-02-04
NO174766C (no) 1994-07-06
GR1000197B (el) 1992-03-20
IT1223799B (it) 1990-09-29
ES2008813A6 (es) 1989-08-01
IT8867791A0 (it) 1988-09-02
FI92553C (fi) 1994-12-12
DK485688A (da) 1989-12-03
AU612398B2 (en) 1991-07-11
FI884057A0 (fi) 1988-09-02
FI92553B (fi) 1994-08-31
MX174157B (es) 1994-04-25
CH675208A5 (de) 1990-09-14
NO883838L (no) 1989-12-04

Similar Documents

Publication Publication Date Title
DE3685094D1 (de) Pharmazeutisches praeparat zur kontrollierten freisetzung von wirkstoffen.
ATA98488A (de) Pharmazeutische verwendung von 17-ketosteroiden
ATA214588A (de) Pharmazeutische dosierungsform zur kontrollierten abgabe von diltiazem
DE122004000023I2 (de) Pharmazeutische Zusammensetzung
FI905684A7 (fi) Farmaseuttinen annosmuoto kalojen lääkintään
DK362189A (da) Farmaceutisk praeparat til intravenoes indgift
ATA204086A (de) Geraet zur verabreichung von medikamenten in pulverform
DE3586713D1 (de) Vorrichtung zur kontrollierten abgabe von arzneimittelwirkstoffen.
FI940787L (fi) Annostusmuoto lääkkeen annostelemiseksi lyhyessä ajanjaksossa
FI913248A0 (fi) Kontrollerat frigoerande fast farmaceutisk doseringsform.
FI920646A7 (fi) Farmaseuttiset aineet
DE3880212D1 (de) Pharmazeutische zusammensetzung zur hautabsorption und hautabsorptionsverstaerkung von medikamenten.
EP0408496A3 (en) Solid dosage form for pharmaceutical substances
FI891774L (fi) Menetelmä lääkeaineen anto- ja/tai annostelumuodon valmistamiseksi
DE3682229D1 (de) Zur stimulierung der traenensekretion verwendbare pharmazeutische praeparate.
DK256290D0 (da) Farmaceutisk praeparat indeholdende deoxyribonucleosider til saarheling
DK23790A (da) Doseringsform til administrering af en calciumantagonist
FI920425A7 (fi) Sykloalkyleeniatsoleja, menetelmä niiden valmistamiseksi niitä sisältä viä farmaseuttisia valmisteita sekä niiden käyttö lääkeaineiden valmis tamiseen
DK298389A (da) Farmaceutisk praeparat til topisk anvendelse omfattende et amin-funktionelt medikament
DK219989A (da) Doseringsbeholder
ATA133288A (de) Pharmazeutische zusammensetzung
IT1223132B (it) Composizione farmaceutica per somministrazione nasale
DK37589D0 (da) Farmaceutisk praeparat for 4-aroylimidazol-2-oner
ATA264087A (de) Pharmazeutische praeparate zur oralen verabreichung
FI930097A7 (fi) Annostusmuoto lääkeaineen antamiseksi vuorokausiterapian toteuttamista varten

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties
ELA Expired due to lapse of time